These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7882470)

  • 21. Microvascular prothrombogenicity and transplant coronary artery disease.
    Labarrere CA; Deng MC
    Transpl Immunol; 2002 May; 9(2-4):243-9. PubMed ID: 12180838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial activation and development of coronary artery disease in transplanted human hearts.
    Labarrere CA; Nelson DR; Faulk WP
    JAMA; 1997 Oct; 278(14):1169-75. PubMed ID: 9326477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation.
    Martí V; Romeo I; Aymat R; García J; Guiteras P; Ballester M; Aminian N; Caralps JM; Augé JM
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1174-80. PubMed ID: 11726893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of vascular remodeling in the pathogenesis of early transplant coronary artery disease: a multicenter prospective intravascular ultrasound study.
    Wong C; Ganz P; Miller L; Kobashigawa J; Schwarzkopf A; Valantine von Kaeper H; Wilensky R; Ventura H; Yeung AC
    J Heart Lung Transplant; 2001 Apr; 20(4):385-92. PubMed ID: 11295575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of intimal thickening on coronary blood flow responses in orthotopic heart transplant recipients. A combined intravascular Doppler and ultrasound imaging study.
    Caracciolo EA; Wolford TL; Underwood RD; Donohue TJ; Bach RG; Miller LW; Kern MJ
    Circulation; 1995 Nov; 92(9 Suppl):II182-90. PubMed ID: 7586405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
    Barr ML; Baker CJ; Schenkel FA; McLaughlin SN; Stouch BC; Starnes VA; Rose EA
    Clin Transplant; 2000 Apr; 14(2):162-6. PubMed ID: 10770423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of inducible endothelial cell adhesion molecule expression for acute rejection of human cardiac allografts.
    Briscoe DM; Yeung AC; Schoen FJ; Allred EN; Stavrakis G; Ganz P; Cotran RS; Pober JS; Schoen EL
    Transplantation; 1995 Jan; 59(2):204-11. PubMed ID: 7530872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of vascular branching sites on focal progression of allograft vasculopathy in transplanted hearts.
    Pethig K; Kofidis T; Heublein B; Westphal A; Haverich A
    Atherosclerosis; 2001 Sep; 158(1):155-60. PubMed ID: 11500186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial cell HLA-DR antigen and myocyte necrosis in human allograft rejection.
    Rabin BS; Griffith BP; Hardesty RL
    J Heart Transplant; 1985 May; 4(3):293-5. PubMed ID: 3916499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts.
    Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(5):724-9. PubMed ID: 8241209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular remodeling 1 year after cardiac transplantation.
    Li H; Tanaka K; Chhabra A; Oeser B; Kobashigawa JA; Tobis JM
    J Heart Lung Transplant; 2007 Jan; 26(1):56-62. PubMed ID: 17234518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
    Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
    Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of graft coronary arteriosclerosis after heart transplantation.
    Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
    Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
    Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P;
    N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression.
    Lou H; Kodama T; Zhao YJ; Maurice P; Wang YN; Katz N; Foegh ML
    Circulation; 1996 Dec; 94(12):3355-61. PubMed ID: 8989151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study.
    Tsutsui H; Ziada KM; Schoenhagen P; Iyisoy A; Magyar WA; Crowe TD; Klingensmith JD; Vince DG; Rincon G; Hobbs RE; Yamagishi M; Nissen SE; Tuzcu EM
    Circulation; 2001 Aug; 104(6):653-7. PubMed ID: 11489770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.
    Ichibori Y; Ohtani T; Nakatani D; Tachibana K; Yamaguchi O; Toda K; Akasaka T; Fukushima N; Sawa Y; Komuro I; Kotani J; Sakata Y
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):51-8. PubMed ID: 25976347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients.
    Itescu S; Tung TC; Burke EM; Weinberg AD; Mancini D; Michler RE; Suciu-Foca NM; Rose EA
    Lancet; 1998 Jul; 352(9124):263-70. PubMed ID: 9690405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The macrophage is the predominant inflammatory cell in renal allograft intimal arteritis.
    Matheson PJ; Dittmer ID; Beaumont BW; Merrilees MJ; Pilmore HL
    Transplantation; 2005 Jun; 79(12):1658-62. PubMed ID: 15973166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.